CompletedPhase 2NCT00334594

Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

Studying Pleural mesothelioma

Last synced from ClinicalTrials.gov May 17, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Swiss Cancer Institute
Principal Investigator: Rolf A. Stahel, Prof
UniversitaetsSpital Zuerich
Intervention: Cisplatin(drug)
Enrollment: 153 enrolled
Eligibility: 18-69 years · All sexes
Timeline: 2005 – 2018

Study locations (13)

Universitaetsklinikum Freiburg, Freiburg im Breisgau, Germany
Kantonsspital Aarau, Aarau, Switzerland
Kantonsspital Baden, Baden, Switzerland
Universitaetsspital-Basel, Basel, Switzerland
Spital Tiefenau, Bern, Switzerland
Inselspital Bern, Bern, Switzerland
Kantonsspital Bruderholz, Bruderholz, Switzerland
Kantonsspital Graubuenden, Chur, Switzerland
Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Kantonsspital Olten, Olten, Switzerland
Kantonsspital - St. Gallen, Sankt Gallen, Switzerland
SpitalSTS AG Simmental-Thun-Saanenland, Thun, Switzerland
UniversitaetsSpital Zuerich, Zurich, Switzerland

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00334594 on ClinicalTrials.gov

Other trials for Pleural mesothelioma

Additional recruiting or active studies for the same condition.

See all trials for Pleural mesothelioma →

← Back to all trials